Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Steroid diabetes in children with Crohn disease (CROSBI ID 101537)

Prilog u časopisu | stručni rad

Banac, Srđan ; Peršić, Mladen ; Cvijović, Katarina Steroid diabetes in children with Crohn disease // Acta medica Croatica, 56 (2002), 33-38-x

Podaci o odgovornosti

Banac, Srđan ; Peršić, Mladen ; Cvijović, Katarina

engleski

Steroid diabetes in children with Crohn disease

Glucocorticoids may be useful as short-term palliative therapy for acute exacerbations of Crohn disease. When glucocorticoids are used longer than brief periods, even in moderate dosages, they can produce a variety of adverse effects, including steroid diabetes. Two boys were treated with methylprednisolone due to acute exacerbations of Crohn disease. After five and six weeks of continous oral administration of methylprednisolone, the boys developed steroid diabetes. Diabetic symptoms dominated the clinical presentation but there was no tendency towards diabetic ketoacidosis. Reduction of methylprednisolone dosage rather than insulin therapy resulted in better control of glycemia. Frequent blood glucose monitoring is recommended in children on prolonged therapy with glucocorticoids. Steroid diabetes experienced by reported cases may be a marker for the onset of diabetes in their adulthood.

adverse effects; children; Crohn disease; glucocorticoids; steroid diabetes

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

56

2002.

33-38-x

objavljeno

1330-0164

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost